Evolus Inc (EOLS)
12.51
+0.06
(+0.48%)
USD |
NASDAQ |
May 24, 16:00
12.52
+0.01
(+0.08%)
After-Hours: 20:00
Evolus Cash from Financing (TTM): 91.58M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 91.58M |
December 31, 2023 | 44.64M |
September 30, 2023 | 19.60M |
June 30, 2023 | 20.26M |
March 31, 2023 | -4.406M |
December 31, 2022 | -4.146M |
September 30, 2022 | 45.26M |
June 30, 2022 | 54.19M |
March 31, 2022 | 148.87M |
December 31, 2021 | 73.05M |
September 30, 2021 | 25.16M |
June 30, 2021 | 56.76M |
March 31, 2021 | -37.39M |
Date | Value |
---|---|
December 31, 2020 | 38.35M |
September 30, 2020 | 111.07M |
June 30, 2020 | 70.84M |
March 31, 2020 | 72.01M |
December 31, 2019 | 133.55M |
September 30, 2019 | 60.82M |
June 30, 2019 | 128.66M |
March 31, 2019 | 127.50M |
December 31, 2018 | 118.84M |
September 30, 2018 | 119.84M |
June 30, 2018 | 55.89M |
March 31, 2018 | 59.42M |
December 31, 2017 | 13.04M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-37.39M
Minimum
Mar 2021
148.87M
Maximum
Mar 2022
57.44M
Average
55.47M
Median
Cash from Financing (TTM) Benchmarks
Viatris Inc | -1.753B |
Shockwave Medical Inc | 522.00M |
Perspective Therapeutics Inc | 167.19M |
Electromed Inc | 0.149M |
Xtant Medical Holdings Inc | 20.30M |